Literature DB >> 3171890

Plasma, cerebrospinal fluid, and brain distribution of 14C-melatonin in rat: a biochemical and autoradiographic study.

P A Vitte1, C Harthe, P Lestage, B Claustrat, P Bobillier.   

Abstract

The distribution of 14C-Melatonin (14C-MT) after systemic injection was studied in the plasma, cerebrospinal fluid (CSF), and brain of rats. Chromatographic analysis (thin-layer chromatography and high-performance liquid chromatography) indicated that the radioactivity from biological samples taken at various times following the injection of label was mainly associated with 14C-MT. Computer analysis of plasma 14C-MT kinetics showed a three-compartment system with half-lives of 0.21 +/- 0.05, 5.97 +/- 1.11, and 47.52 +/- 8.86 min. The volume of distribution and the clearance were 1,736 +/- 349 ml.kg-1 and 25.1 +/- 1.7 ml.min-1.kg-1 respectively. The entry of 14C-MT into the CSF was rapid and reached a maximum at 5 min. The decay followed a two-compartment system with half-lives of 16.5 +/- 2.9 and 47.3 +/- 8.6 min. The CSF/plasma concentration ratio was 0.38 at the steady state (30 min). At 2 min the level of 14C-MT in the brain was 3.8 higher than in the CSF. Representative autoradiograms revealed an heterogeneous localization of 14C-MT in the grey matter. The highest regional values, as evaluated by the permeability area product technique, were found in cortex, thalamic nuclei, medial geniculate nucleus, anterior pretectal area, paraventricular nucleus of the hypothalamus, choroid plexuses, and bulb-pons. Thirty minutes later 14C-MT was still detected in most of the brain regions analyzed. These results point to a low but rapid penetration of circulating MT into the brain and the CSF. The heterogeneous distribution and the partial retention of 14C-MT in the brain are compatible with the hypothesis of a central action of this hormone mediated via binding sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171890     DOI: 10.1111/j.1600-079x.1988.tb00787.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  10 in total

1.  Brief report: circadian melatonin, thyroid-stimulating hormone, prolactin, and cortisol levels in serum of young adults with autism.

Authors:  I Nir; D Meir; N Zilber; H Knobler; J Hadjez; Y Lerner
Journal:  J Autism Dev Disord       Date:  1995-12

Review 2.  Neuroprotection Strategies in Preterm Encephalopathy.

Authors:  Pratik Parikh; Sandra E Juul
Journal:  Semin Pediatr Neurol       Date:  2019-08-09       Impact factor: 1.636

3.  Reduction in traumatic brain injury-induced oxidative stress, apoptosis, and calcium entry in rat hippocampus by melatonin: Possible involvement of TRPM2 channels.

Authors:  Vehbi Yürüker; Mustafa Nazıroğlu; Nilgün Şenol
Journal:  Metab Brain Dis       Date:  2014-10-23       Impact factor: 3.584

Review 4.  Which neuroprotective agents are ready for bench to bedside translation in the newborn infant?

Authors:  Nicola J Robertson; Sidhartha Tan; Floris Groenendaal; Frank van Bel; Sandra E Juul; Laura Bennet; Matthew Derrick; Stephen A Back; Raul Chavez Valdez; Frances Northington; Alistair Jan Gunn; Carina Mallard
Journal:  J Pediatr       Date:  2012-02-09       Impact factor: 4.406

Review 5.  Neonatal Encephalopathy: Update on Therapeutic Hypothermia and Other Novel Therapeutics.

Authors:  Ryan M McAdams; Sandra E Juul
Journal:  Clin Perinatol       Date:  2016-06-22       Impact factor: 3.430

Review 6.  Sensory and sympathetic nervous system control of white adipose tissue lipolysis.

Authors:  Timothy J Bartness; Y B Shrestha; C H Vaughan; G J Schwartz; C K Song
Journal:  Mol Cell Endocrinol       Date:  2009-09-10       Impact factor: 4.102

Review 7.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

8.  Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism.

Authors:  Federica Gevi; Lello Zolla; Stefano Gabriele; Antonio M Persico
Journal:  Mol Autism       Date:  2016-11-24       Impact factor: 7.509

9.  Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum.

Authors:  Yuguang Zhao; Jingshan Ren; James Hillier; Margaret Jones; Weixian Lu; Edith Yvonne Jones
Journal:  J Pineal Res       Date:  2020-01-24       Impact factor: 13.007

Review 10.  Protective role of melatonin in neonatal diseases.

Authors:  Eloisa Gitto; Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Ignazio Barberi; Carmelo Salpietro; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2013-11-19       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.